Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Karolinska Institute
- License Information
-
More Information
Article History
Received: 23 September 2020
Accepted: 19 April 2021
First Online: 6 May 2021
Change Date: 29 October 2021
Change Type: Update
Change Details: The funding note “Open access funding provided by Karolinska Institute” was added. The article has been updated.
Declarations
:
: Not applicable.
: Ethical approvals were obtained by the Regional Ethics Committee of Stockholm, Sweden, as 2009/1091–31/2 (on September 18, 2009); the Regional Ethics Committee of Linköping, Sweden, as M114–09 (June 17, 2009), 2011/101–31 May 20, 2011), and 2010/241–31 September 29, 2010); and by the Cantonal Ethics Committee KEK Bern, Switzerland, KEKBE ID 2018–02351 (on February 20, 2019). The corresponding registrations at were NCT01195025, NCT 01062776, NCT01458678, NCT01360333, and NCT 03848507. All patients gave us their written informed consent to participate.
: RGH holds a grant from Grifols for the study of 20% albumin as infusion fluid.The other authors declare that they have no conflict of interest.
